Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Vosoritide> ?p ?o }
Showing triples 1 to 85 of
85
with 100 triples per page.
- Vosoritide abstract "Vosoritide (INN, codenamed BMN-111) is an experimental drug for the treatment of achondroplasia, the most common cause of dwarfism. It is being developed by BioMarin Pharmaceutical and, being the only available causal treatment for this condition, has orphan drug status in the US as well as Europe. As of September 2015, it is in Phase II clinical trials.".
- Vosoritide thumbnail Vosoritide_mechanism.png?width=300.
- Vosoritide wikiPageID "47764552".
- Vosoritide wikiPageLength "8194".
- Vosoritide wikiPageOutDegree "47".
- Vosoritide wikiPageRevisionID "683199200".
- Vosoritide wikiPageWikiLink Achondroplasia.
- Vosoritide wikiPageWikiLink Acidic_fibroblast_growth_factor.
- Vosoritide wikiPageWikiLink Alanine.
- Vosoritide wikiPageWikiLink Arginine.
- Vosoritide wikiPageWikiLink Asparagine.
- Vosoritide wikiPageWikiLink Aspartic_acid.
- Vosoritide wikiPageWikiLink Basic_fibroblast_growth_factor.
- Vosoritide wikiPageWikiLink BioMarin_Pharmaceutical.
- Vosoritide wikiPageWikiLink Body_proportions.
- Vosoritide wikiPageWikiLink C-terminal.
- Vosoritide wikiPageWikiLink C-terminus.
- Vosoritide wikiPageWikiLink C-type_natriuretic_peptide.
- Vosoritide wikiPageWikiLink Cartilage.
- Vosoritide wikiPageWikiLink Category:Dwarfism.
- Vosoritide wikiPageWikiLink Category:Orphan_drugs.
- Vosoritide wikiPageWikiLink Cell_growth.
- Vosoritide wikiPageWikiLink Cell_proliferation.
- Vosoritide wikiPageWikiLink Chondrocyte.
- Vosoritide wikiPageWikiLink Clinical_trial.
- Vosoritide wikiPageWikiLink Cysteine.
- Vosoritide wikiPageWikiLink Disulfide.
- Vosoritide wikiPageWikiLink Disulfide_bridge.
- Vosoritide wikiPageWikiLink Dwarfism.
- Vosoritide wikiPageWikiLink FGF1.
- Vosoritide wikiPageWikiLink Fibroblast_growth_factor_receptor_3.
- Vosoritide wikiPageWikiLink Glutamic_acid.
- Vosoritide wikiPageWikiLink Glutamine.
- Vosoritide wikiPageWikiLink Glycine.
- Vosoritide wikiPageWikiLink Histidine.
- Vosoritide wikiPageWikiLink Hydrocephalus.
- Vosoritide wikiPageWikiLink International_Nonproprietary_Name.
- Vosoritide wikiPageWikiLink Isoleucine.
- Vosoritide wikiPageWikiLink Leucine.
- Vosoritide wikiPageWikiLink Lysine.
- Vosoritide wikiPageWikiLink Methionine.
- Vosoritide wikiPageWikiLink Mouth.
- Vosoritide wikiPageWikiLink Natriuretic_peptide_precursor_C.
- Vosoritide wikiPageWikiLink Orphan_drug.
- Vosoritide wikiPageWikiLink P-value.
- Vosoritide wikiPageWikiLink Peptide.
- Vosoritide wikiPageWikiLink Peptide_sequence.
- Vosoritide wikiPageWikiLink Phenylalanine.
- Vosoritide wikiPageWikiLink Proline.
- Vosoritide wikiPageWikiLink Receptor_(biochemistry).
- Vosoritide wikiPageWikiLink Serine.
- Vosoritide wikiPageWikiLink Sleep_apnea.
- Vosoritide wikiPageWikiLink Subcutaneous_injection.
- Vosoritide wikiPageWikiLink Tyrosine.
- Vosoritide wikiPageWikiLink File:Vosoritide_mechanism.png.
- Vosoritide wikiPageWikiLinkText "vosoritide".
- Vosoritide atcPrefix "none".
- Vosoritide c "176".
- Vosoritide casNumber "1480724".
- Vosoritide h "290".
- Vosoritide hasPhotoCollection Vosoritide.
- Vosoritide legalStatus "Investigational".
- Vosoritide n "56".
- Vosoritide o "51".
- Vosoritide routesOfAdministration Subcutaneous_injection.
- Vosoritide s "3".
- Vosoritide synonyms "BMN-111".
- Vosoritide unii "7".
- Vosoritide wikiPageUsesTemplate Template:As_of.
- Vosoritide wikiPageUsesTemplate Template:Convert.
- Vosoritide wikiPageUsesTemplate Template:Infobox_drug.
- Vosoritide wikiPageUsesTemplate Template:Reflist.
- Vosoritide subject Category:Dwarfism.
- Vosoritide subject Category:Orphan_drugs.
- Vosoritide hypernym Drug.
- Vosoritide type ChemicalSubstance.
- Vosoritide type Drug.
- Vosoritide type ChemicalObject.
- Vosoritide type Thing.
- Vosoritide type Q8386.
- Vosoritide comment "Vosoritide (INN, codenamed BMN-111) is an experimental drug for the treatment of achondroplasia, the most common cause of dwarfism. It is being developed by BioMarin Pharmaceutical and, being the only available causal treatment for this condition, has orphan drug status in the US as well as Europe. As of September 2015, it is in Phase II clinical trials.".
- Vosoritide label "Vosoritide".
- Vosoritide wasDerivedFrom Vosoritide?oldid=683199200.
- Vosoritide depiction Vosoritide_mechanism.png.
- Vosoritide isPrimaryTopicOf Vosoritide.